ID

39093

Description

Safety and Efficacy of BKM120 in Relapsed and Refractory NHL; ODM derived from: https://clinicaltrials.gov/show/NCT01693614

Link

https://clinicaltrials.gov/show/NCT01693614

Keywords

Versions (1)
  1. 12/1/19 12/1/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

December 1, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma NCT01693614

English

Eligibility Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma NCT01693614

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patient has a histologically confirmed diagnosis of mantle cell lymphoma, follicular lymphoma, or diffuse large b cell lymphoma.
Description

Mantle cell lymphoma | Lymphoma, Follicular | Diffuse Large B-Cell Lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C0334634
UMLS CUI [2]
C0024301
UMLS CUI [3]
C0079744
2. patient has relapsed or refractory disease and received at least one prior therapy.
Description

Recurrent disease | Refractory Disease | Prior Therapy Quantity

Data type

boolean

Alias
UMLS CUI [1]
C0277556
UMLS CUI [2]
C1514815
UMLS CUI [3,1]
C1514463
UMLS CUI [3,2]
C1265611
3. patient with diffuse large b cell lymphoma has received or is ineligible for autologous or allogeneic stem cell transplant.
Description

Diffuse Large B-Cell Lymphoma | Autologous hematopoietic stem cell transplant | Allogeneic hematopoietic stem cell transplant | Patient Ineligible Autologous hematopoietic stem cell transplant | Patient Ineligible Allogeneic hematopoietic stem cell transplant

Data type

boolean

Alias
UMLS CUI [1]
C0079744
UMLS CUI [2]
C2193200
UMLS CUI [3]
C4255274
UMLS CUI [4,1]
C0030705
UMLS CUI [4,2]
C1512714
UMLS CUI [4,3]
C2193200
UMLS CUI [5,1]
C0030705
UMLS CUI [5,2]
C1512714
UMLS CUI [5,3]
C4255274
4. patient has at least one measurable nodal lesion (≥2 cm) according to cheson criteria (cheson 2007). in case where the patient has no measurable nodal lesions ≥ 2 cm in the long axis at baseline, then the patient must have at least one measurable extra-nodal lesion.
Description

Lesion nodal Quantity | Measurable lesion nodal Size | Measurable lesion Extranodal Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C0221198
UMLS CUI [1,2]
C0443268
UMLS CUI [1,3]
C1265611
UMLS CUI [2,1]
C1513041
UMLS CUI [2,2]
C0443268
UMLS CUI [2,3]
C0456389
UMLS CUI [3,1]
C1513041
UMLS CUI [3,2]
C1517067
UMLS CUI [3,3]
C1265611
5. patient has an eastern cooperative oncology group (ecog) performance status ≤ 2.
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
6. patient has adequate bone marrow and organ function.
Description

Bone Marrow function | Organ function

Data type

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0678852
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. patient has received previous treatment with pi3k inhibitors
Description

PI3K inhibitor

Data type

boolean

Alias
UMLS CUI [1]
C1519050
2. patient has evidence of graft versus host disease (gvhd).
Description

Graft-vs-Host Disease

Data type

boolean

Alias
UMLS CUI [1]
C0018133
3. patient has active or history of central nervous system (cns) disease.
Description

CNS disorder

Data type

boolean

Alias
UMLS CUI [1]
C0007682
4. patient has a concurrent malignancy or has a malignancy within 3 years of study enrollment (with the exception of adequately treated basal or squamous cell carcinoma or non-melanomatous skin cancer).
Description

Cancer Other | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Exception Skin carcinoma Treated

Data type

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007117
UMLS CUI [2,3]
C1522326
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0553723
UMLS CUI [3,3]
C1522326
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0699893
UMLS CUI [4,3]
C1522326
5. patient has a score ≥ 12 on the phq-9 questionnaire.
Description

Patient Health Questionnaire - 9 Item

Data type

boolean

Alias
UMLS CUI [1]
C4083201
6. patient has a gad-7 mood scale score ≥ 15.
Description

GAD-7

Data type

boolean

Alias
UMLS CUI [1]
C3641330
7. pregnant or nursing women
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
8. patient who does not use highly effective contraception methods to avoid becoming pregnant or conceiving offspring.
Description

Contraceptive methods Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C0332197
other protocol-defined inclusion/exclusion criteria may apply.
Description

Eligibility Criteria Study Protocol

Data type

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Back to the top of the page

Similar models

Eligibility Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma NCT01693614

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Mantle cell lymphoma | Lymphoma, Follicular | Diffuse Large B-Cell Lymphoma
Item
1. patient has a histologically confirmed diagnosis of mantle cell lymphoma, follicular lymphoma, or diffuse large b cell lymphoma.
boolean
C0334634 (UMLS CUI [1])
C0024301 (UMLS CUI [2])
C0079744 (UMLS CUI [3])
Recurrent disease | Refractory Disease | Prior Therapy Quantity
Item
2. patient has relapsed or refractory disease and received at least one prior therapy.
boolean
C0277556 (UMLS CUI [1])
C1514815 (UMLS CUI [2])
C1514463 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
Diffuse Large B-Cell Lymphoma | Autologous hematopoietic stem cell transplant | Allogeneic hematopoietic stem cell transplant | Patient Ineligible Autologous hematopoietic stem cell transplant | Patient Ineligible Allogeneic hematopoietic stem cell transplant
Item
3. patient with diffuse large b cell lymphoma has received or is ineligible for autologous or allogeneic stem cell transplant.
boolean
C0079744 (UMLS CUI [1])
C2193200 (UMLS CUI [2])
C4255274 (UMLS CUI [3])
C0030705 (UMLS CUI [4,1])
C1512714 (UMLS CUI [4,2])
C2193200 (UMLS CUI [4,3])
C0030705 (UMLS CUI [5,1])
C1512714 (UMLS CUI [5,2])
C4255274 (UMLS CUI [5,3])
Lesion nodal Quantity | Measurable lesion nodal Size | Measurable lesion Extranodal Quantity
Item
4. patient has at least one measurable nodal lesion (≥2 cm) according to cheson criteria (cheson 2007). in case where the patient has no measurable nodal lesions ≥ 2 cm in the long axis at baseline, then the patient must have at least one measurable extra-nodal lesion.
boolean
C0221198 (UMLS CUI [1,1])
C0443268 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C1513041 (UMLS CUI [2,1])
C0443268 (UMLS CUI [2,2])
C0456389 (UMLS CUI [2,3])
C1513041 (UMLS CUI [3,1])
C1517067 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
ECOG performance status
Item
5. patient has an eastern cooperative oncology group (ecog) performance status ≤ 2.
boolean
C1520224 (UMLS CUI [1])
Bone Marrow function | Organ function
Item
6. patient has adequate bone marrow and organ function.
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0678852 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
PI3K inhibitor
Item
1. patient has received previous treatment with pi3k inhibitors
boolean
C1519050 (UMLS CUI [1])
Graft-vs-Host Disease
Item
2. patient has evidence of graft versus host disease (gvhd).
boolean
C0018133 (UMLS CUI [1])
CNS disorder
Item
3. patient has active or history of central nervous system (cns) disease.
boolean
C0007682 (UMLS CUI [1])
Cancer Other | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Exception Skin carcinoma Treated
Item
4. patient has a concurrent malignancy or has a malignancy within 3 years of study enrollment (with the exception of adequately treated basal or squamous cell carcinoma or non-melanomatous skin cancer).
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0553723 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0699893 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
Patient Health Questionnaire - 9 Item
Item
5. patient has a score ≥ 12 on the phq-9 questionnaire.
boolean
C4083201 (UMLS CUI [1])
GAD-7
Item
6. patient has a gad-7 mood scale score ≥ 15.
boolean
C3641330 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
7. pregnant or nursing women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Contraceptive methods Absent
Item
8. patient who does not use highly effective contraception methods to avoid becoming pregnant or conceiving offspring.
boolean
C0700589 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial